On November 23, the University of Toronto’s Emerging and Pandemic Infections Consortium (EPIC) partnered with diagnostics industry leader bioMérieux Canada to jointly host a research symposium on Canadian perspectives on antimicrobial resistance: where we are now and looking ahead.
Meet Susy Hota, medical director of Infection Prevention and Control and an infectious disease specialist at the University Health Network. She is also an associate professor in the department of medicine at the Temerty Faculty of Medicine at the University of Toronto and co-lead of the University of Toronto Microbiota Therapeutics Outcomes Program.
As the global health and research communities mark World Antimicrobial Awareness Week, members of the Emerging and Pandemic Infections Consortium (EPIC) are making strides in the fight against antimicrobial resistance. L